Fastclav 500 Tablet is a potent antibiotic formulation combining Cefuroxime 500mg and Clavulanic Acid 125mg, designed to effectively combat a wide range of bacterial infections. Cefuroxime, a second-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefuroxime by preventing the breakdown of the antibiotic by beta-lactamase enzymes produced by resistant bacteria. This combination makes Fastclav 500 highly effective against infections caused by beta-lactamase producing strains, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sinusitis. It is typically prescribed when monotherapy with Cefuroxime alone is insufficient due to resistance. Fastclav 500 is administered orally, with dosage and duration depending on the severity and type of infection, and should be taken as directed by a healthcare professional. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, but it is generally well tolerated. Patients with a history of hypersensitivity to cephalosporins or penicillins should use this medication cautiously. Fastclav 500 Tablet is a reliable choice for treating bacterial infections where resistance is a concern, ensuring effective and broad-spectrum antimicrobial coverage.